These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 26250523)
1. Thymosin α1 plus routine treatment inhibit inflammatory reaction and improve the quality of life in AECOPD patients. Jia Z; Feng Z; Tian R; Wang Q; Wang L Immunopharmacol Immunotoxicol; 2015; 37(4):388-92. PubMed ID: 26250523 [TBL] [Abstract][Full Text] [Related]
2. The role of Tα1 on the infective patients after hematopoietic stem cell transplantation. Ding JH; Wang LL; Chen Z; Wang J; Yu ZP; Zhao G; Chen BA Int J Hematol; 2013 Feb; 97(2):280-3. PubMed ID: 23307511 [TBL] [Abstract][Full Text] [Related]
3. [The prophylactic effect of thymosin alpha 1 on the acute exacerbation of chronic obstructive pulmonary disease]. Zheng BX; Cheng DY; Xu G; Fan LL; Yang Y; Yang W Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Jul; 39(4):588-90. PubMed ID: 18798500 [TBL] [Abstract][Full Text] [Related]
4. A pilot study of thymosin alpha1 therapy for chronic hepatitis B patients. Arase Y; Tsubota A; Suzuki Y; Suzuki F; Kobayashi M; Someya T; Akuta N; Hosaka T; Saitoh S; Ikeda K; Kobayashi M; Kumada H Intern Med; 2003 Oct; 42(10):941-6. PubMed ID: 14606705 [TBL] [Abstract][Full Text] [Related]
5. Thymosin alpha1 treatment of chronic hepatitis B: results of a phase III multicentre, randomized, double-blind and placebo-controlled study. Mutchnick MG; Lindsay KL; Schiff ER; Cummings GD; Appelman HD; Peleman RR; Silva M; Roach KC; Simmons F; Milstein S; Gordon SC; Ehrinpreis MN J Viral Hepat; 1999 Sep; 6(5):397-403. PubMed ID: 10607256 [TBL] [Abstract][Full Text] [Related]
6. The efficacy of thymosin α1 as immunomodulatory treatment for sepsis: a systematic review of randomized controlled trials. Liu F; Wang HM; Wang T; Zhang YM; Zhu X BMC Infect Dis; 2016 Sep; 16():488. PubMed ID: 27633969 [TBL] [Abstract][Full Text] [Related]
7. The efficacy of thymosin alpha 1 for severe sepsis (ETASS): a multicenter, single-blind, randomized and controlled trial. Wu J; Zhou L; Liu J; Ma G; Kou Q; He Z; Chen J; Ou-Yang B; Chen M; Li Y; Wu X; Gu B; Chen L; Zou Z; Qiang X; Chen Y; Lin A; Zhang G; Guan X Crit Care; 2013 Jan; 17(1):R8. PubMed ID: 23327199 [TBL] [Abstract][Full Text] [Related]
8. Treatment of patients with severe sepsis using ulinastatin and thymosin alpha1: a prospective, randomized, controlled pilot study. Chen H; He MY; Li YM Chin Med J (Engl); 2009 Apr; 122(8):883-8. PubMed ID: 19493408 [TBL] [Abstract][Full Text] [Related]
9. Thymalfasin for the treatment of chronic hepatitis B. Chien RN; Liaw YF Expert Rev Anti Infect Ther; 2004 Feb; 2(1):9-16. PubMed ID: 15482167 [TBL] [Abstract][Full Text] [Related]
10. A randomized, controlled, clinical study of thymosin alpha-1 versus interferon-alpha in [corrected] patients with chronic hepatitis B lacking HBeAg in China [corrected]. You J; Zhuang L; Cheng HY; Yan SM; Qiao YW; Huang JH; Tang BZ; Ma YL; Wu GB; Qu JY; Wu RX J Chin Med Assoc; 2005 Feb; 68(2):65-72. PubMed ID: 15759817 [TBL] [Abstract][Full Text] [Related]
11. Thymosin-alpha1 and famciclovir combination therapy activates T-cell response in patients with chronic hepatitis B virus infection in immune-tolerant phase. Lau GK; Nanji A; Hou J; Fong DY; Au WS; Yuen ST; Lin M; Kung HF; Lam SK J Viral Hepat; 2002 Jul; 9(4):280-7. PubMed ID: 12081605 [TBL] [Abstract][Full Text] [Related]
13. Thymosin-alpha 1 plus interferon-alpha for naive patients with chronic hepatitis C: results of a randomized controlled pilot trial. Andreone P; Gramenzi A; Cursaro C; Felline F; Loggi E; D'Errico A; Spinosa M; Lorenzini S; Biselli M; Bernardi M J Viral Hepat; 2004 Jan; 11(1):69-73. PubMed ID: 14738560 [TBL] [Abstract][Full Text] [Related]
14. The efficacy and safety of thymosin alpha-1 in Japanese patients with chronic hepatitis B; results from a randomized clinical trial. Iino S; Toyota J; Kumada H; Kiyosawa K; Kakumu S; Sata M; Suzuki H; Martins EB J Viral Hepat; 2005 May; 12(3):300-6. PubMed ID: 15850471 [TBL] [Abstract][Full Text] [Related]
15. Thymosin-alpha1 promotes the apoptosis of regulatory T cells and survival rate in septic mice. Wan J; Shan Y; Shan H; Li G; Wang T; Guan J; Liu X; Chen D; Li W; Lin Z Front Biosci (Landmark Ed); 2011 Jun; 16(8):3004-13. PubMed ID: 21622217 [TBL] [Abstract][Full Text] [Related]
16. [Effects of thymosin-alpha1 on cell immunity function in patients with septic shock]. Chen J Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Mar; 19(3):153-5. PubMed ID: 17376268 [TBL] [Abstract][Full Text] [Related]
17. The Therapeutic Effects of Thymosin α1 Combined with Human Immunoglobulin (Ig) and Bundles on Severe Sepsis: a Retrospective Study. Li Y; Li CS Clin Lab; 2015; 61(8):907-16. PubMed ID: 26427133 [TBL] [Abstract][Full Text] [Related]
18. Thymosin alpha 1 is associated with improved cellular immunity and reduced infection rate in severe acute pancreatitis patients in a double-blind randomized control study. Wang X; Li W; Niu C; Pan L; Li N; Li J Inflammation; 2011 Jun; 34(3):198-202. PubMed ID: 20549321 [TBL] [Abstract][Full Text] [Related]
19. A randomized, controlled study of thymosin-alpha1 therapy in patients with anti-HBe, HBV-DNA-positive chronic hepatitis B. Zavaglia C; Severini R; Tinelli C; Franzone JS; Airoldi A; Tempini S; Bettale G; Ideo G Dig Dis Sci; 2000 Apr; 45(4):690-6. PubMed ID: 10759236 [TBL] [Abstract][Full Text] [Related]
20. Bioactivity and pharmacokinetics of two human serum albumin-thymosin alpha1-fusion proteins, rHSA-Talpha1 and rHSA-L-Talpha1, expressed in recombinant Pichia pastoris. Chen JH; Zhang XG; Jiang YT; Yan LY; Tang L; Yin YW; Cheng DS; Chen J; Wang M Cancer Immunol Immunother; 2010 Sep; 59(9):1335-45. PubMed ID: 20473755 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]